Astellas To Co-market Japanese Encephalitis Vaccine In Japan
This article was originally published in PharmAsia News
Executive Summary
Astellas and Kumamot- based Chemo-Sero-Therapeutic Institute (Kaketsukan) has signed a deal to co-market Japanese encephalitis vaccine in Japan